BMEA (Biomea Fusion Corp) Wutah bathi ing taun lumaku
Risks are associated with the potential failure of final tests for new drugs at Biomea Fusion, Inc. (BMEA). The annual EPS change metric demonstrates a support level where the indicator value reaches 45.40. The expansion of the covalent inhibitor platform for diabetes therapy fuels optimism, although global pharma behemoths fighting for dominance in the metabolic disorders market are creating pressure.
Rincian metrik keuangan lan pasar Biomea Fusion Inc (BMEA)
- rega saham lan prakiraan rega para ahli:
- indikator valuasi pasar bisnis:
- data kapitalisasi buku:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Biomea Fusion, Inc.|BMEA - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Biomea Fusion Inc|BMEA - Utang perusahaan|Utang-utang marang aset resik Biomea Fusion, Inc.|BMEA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Biomea Fusion|Likuiditas cepet biomeafusion.com
- informasi bathi lan kelipatan valuasi:
BMEA - Bathi resik|Prakiraan bathi perusahaan Biomea Fusion, Inc.|BMEA - Rasio rega marang bathi|Rasio prakiraan rega marang bathi biomeafusion.com|BMEA - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Biomea Fusion|BMEA - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Biomea Fusion|BMEA - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan biomeafusion.com|BMEA - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Biomea Fusion, Inc.
- data pendapatan lan penerimaan dodolan:
Analisis dhasar perusahaan:BMEA - Biomea Fusion Corp
This indicator measures the dynamics of net income per share, reflecting the year-over-year rate of change in business profitability based on reported data. During a slowdown phase, the relative annual growth of net income per share becomes a critical marker of stability for Biomea Fusion, Inc. (BMEA), as any negative clinical trial results for its drugs would immediately destabilize this fundamental metric.
Pesaing utama
ASND: Wutah bathi resik saben siji saham kanggo taun lumaku|MDGL (Madrigal Corp) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Corcept Therapeutics|Wutah bathi ing taun lumaku RYTM|Wutah bathi saben saham ing taun lumaku AKRO (Akero Therapeutics, Inc.)|Wutah bathi saben saham ing taun lumaku metsera.com MTSR|MoonLake Corp (MLTX) - Kacepetan wutah bathi saben saham ing taun lumaku|CRNX - Wutah bathi saben saham ing taun lumaku|NAMS: Wutah bathi saben saham ing taun lumaku|SLNO: Wutah bathi ing taun lumaku|FOLD - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku 89bio Pharma|Agios Corp (AGIO) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku structuretx.com (GPCR)|Wutah bathi resik saben saham ing taun iki mimedx.com MDXG|Wutah bathi saben saham ing taun lumaku Rezolute RZLT|Lexicon Pharmaceuticals, Inc. - Wutah bathi saben saham ing taun lumaku|MBX: Wutah bathi resik saben saham ing taun iki|Altimmune Corp - Wutah bathi resik saben siji saham kanggo taun lumaku|Aardvark Therapeutics Inc (AARD) - Wutah bathi saben saham ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku Sagimet Biosciences SGMT|BIOA (bioagelabs.com) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki QNCX (Quince Therapeutics)|Wutah bathi resik saben saham ing taun iki GUTS (Fractyl Health)|Wutah bathi resik saben siji saham kanggo taun lumaku VTVT|Agape ATP Corporation - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku PLUR|Synlogic Inc. - Wutah bathi ing taun lumaku|LPCN (Lipocine) - Wutah bathi saben saham ing taun iki|MTNB (Matinas BioPharma Holdings Inc.) - Wutah bathi resik saben saham ing taun iki|SPRB (Spruce Biosciences, Inc.) - Wutah bathi saben saham ing taun lumaku|GLTO (galecto.com) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki carmellrx.com (CTCX)|Wutah bathi saben saham ing taun lumaku Lumos Pharma (LUMO)|ONVO (Organovo Holdings) - Tambahing bathi saben saham ing taun lumaku|radiuspharm.com - Wutah bathi resik saben saham ing taun iki
